7Baggers

DocGo Inc
(NASDAQ:DCGO) 

DCGO stock logo

DocGo, Inc. operates as a health care distribution company. The Company offers mobile health services and integrated medical mobility solutions. DocGo serves customers in the United States.

Founded: 2015
Sector: Healthcare
Industry: ...

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 
                        
      revenues
    75,550,484 74,935,688 70,809,635 80,417,622 96,033,055 120,833,073 138,684,814 164,949,716 192,087,529 199,246,269 186,552,910          
      expenses:
                        
      cost of revenues
    51,667,588 50,571,192 52,683,525 54,998,524 65,185,060 80,334,624 88,764,282 109,072,737 124,808,914 132,559,805 131,502,046 83,617,876 81,226,498 66,375,647 71,254,838 70,176,462 77,987,573    
      operating expenses:
                        
      general and administrative
    30,835,068 39,214,798 30,091,786 31,240,943 32,902,070 35,041,780 28,784,850 34,751,093 40,181,035 43,514,996 33,619,962 30,797,237 29,220,317 32,719,146 22,186,036 24,637,618 23,860,616    
      depreciation and amortization
    2,647,107 3,948,234 3,971,232 3,981,008 3,761,391 3,322,925 4,177,534 4,201,658 4,182,781 4,615,235 4,336,267 3,831,061 3,649,329 3,311,922 3,014,864 2,037,771 2,201,021    
      legal and regulatory
    5,034,130 9,530,093 5,727,008 4,351,974 4,210,823 5,524,453 3,295,139 4,013,796 4,313,503 3,493,572 3,545,820 2,404,856 3,638,321 2,170,367 2,200,964 3,061,276 1,347,983    
      technology and development
    3,705,049 3,772,943 3,193,480 2,957,203 3,639,444 3,685,650 3,145,834 2,368,999 2,388,919 3,185,455 3,235,301 2,574,389 1,863,579 1,721,554 1,373,146 1,148,320 1,141,833    
      sales, advertising and marketing
    372,633 340,337 380,172 368,214 331,705 396,828 379,778 392,284 337,010 203,548 1,605,559 685,387 307,246 2,406,244 90,856 1,000,100 1,257,961    
      total expenses
    94,261,575 179,515,197 112,785,944 97,897,866 110,030,493 128,306,260 128,547,417 154,800,567 176,212,162 187,572,611 177,844,955 123,910,806 119,905,290 108,704,880 100,120,704 102,061,547 107,796,987    
      income from operations
    -18,711,091 -104,579,509 -41,976,309 -17,480,244 -13,997,438 -7,473,187 10,137,397 10,149,149 15,875,367 11,673,658 8,707,955 1,575,954 -6,902,587 80,116 4,199,190 7,457,757 10,094,565 16,333,784 -348,325 -245,345 
      yoy
    33.68% 1299.40% -514.07% -272.23% -188.17% -164.02% 16.42% 544.00% -329.99% 14470.94% 107.37% -78.87% -168.38% -99.51% -1305.54% -3139.70%     
      qoq
    -82.11% 149.14% 140.14% 24.88% 87.30% -173.72% -0.12% -36.07% 35.99% 34.06% 452.55% -122.83% -8715.74% -98.09% -43.69% -26.12% -38.20% -4789.24% 41.97%  
      operating margin %
    -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% 1.26% -6.11% 0.07% 4.03% 6.81% 8.56% Infinity% -Infinity% -Infinity% 
      other income:
                        
      interest expense
    -99,732 -272,451.75 -219,861 -443,662 -426,284                
      loss on change in fair value of contingent consideration
    -2,760,000 -263,098.5 -1,052,394                  
      insurance proceeds
    4,687,798                    
      loss on equity method investment
                        
      loss on remeasurement of operating and finance leases
       -6,607 -40,837   -21,192 -4,697            
      gain on disposal of fixed assets
    -62,493 -10,917 -10,453 -48,354 15,139 -13,035 -28,681 12,563 52,835 -40,863 -9,983 -98,630  10,666.75 42,667      
      other income
    264,964 -432,779 112,184 101,046 -312,869 82,608 -435,825 337,276 244,607 -165,456.25 43,353 -920,058 214,880 10,572 30,900 15,640 -4,253    
      total other income
    2,030,537     897,931 -1,103,016 -581,655 -152,984 522,724 449,051 -587,389 853,927 -2,056,765 -1,330,788 4,619,765 -281,949 3,969,613 892,812 -2,797,222 
      net loss before income tax benefit
    -16,680,554                    
      benefit from income taxes
    -19,283 5,465,465.25 13,511,429 4,626,745 3,723,687   -3,708,920 -5,119,004            
      net income
    -16,699,837 -142,340,600 -29,657,362 -13,289,893 -11,079,300 -7,646,926 4,545,553 5,858,574 10,603,379 7,993,260 4,630,239 1,343,619 -3,918,790 7,148,427 2,466,486 11,755,862 9,372,437 19,687,700 544,487 -3,042,567 
      yoy
    50.73% 1761.41% -752.45% -326.85% -204.49% -195.67% -1.83% 336.03% -370.58% 11.82% 87.73% -88.57% -141.81% -63.69% 352.99% -486.38%     
      qoq
    -88.27% 379.95% 123.16% 19.95% 44.89% -268.23% -22.41% -44.75% 32.65% 72.63% 244.61% -134.29% -154.82% 189.82% -79.02% 25.43% -52.39% 3515.83% -117.90%  
      net income margin %
    -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% 1.07% -3.47% 6.57% 2.36% 10.73% 7.95% Infinity% Infinity% -Infinity% 
      net loss attributable to noncontrolling interests
    -1,936,706 -1,424,402 -1,888,976 -2,134,647 -1,673,985    -624,070     -916,293 -687,944  -1,257,257    
      net loss attributable to stockholders of docgo inc. and subsidiaries
    -14,763,131                    
      other comprehensive income
                        
      unrealized loss on investments, net of tax
    -71,904                    
      foreign currency translation adjustment
    -67,516 -23,249 -319,851 927,462 495,538 -1,091,649 934,774 33,973 -140,134 676,734 -582,471 405,778 243,658 520,853 248,283 10,434 -5,863    
      total comprehensive loss
    -14,902,551                    
      net income per share
    -0.15 -1.35 -0.28 -0.11 -0.09 -0.03 0.05 0.06 0.11 0.08 0.05 -0.02 -0.03 0.08 0.03 0.13 0.11    
      weighted-average shares outstanding - basic
    98,746,095 99,068,651 97,808,976 98,931,293 101,594,579 102,395,141 102,067,579 101,840,612 103,818,362 103,511,299 103,874,845 103,585,661 102,579,291  98,960,538 99,303,948 100,177,082 80,293,959   
      weighted-average shares outstanding - diluted
    98,746,095 99,068,651 97,808,976 98,931,293 101,594,579 109,422,840 106,290,929 106,324,345 108,506,435 105,617,817 104,993,729 103,585,661 102,579,291  107,403,135 115,279,676 115,652,049 94,863,613   
      finite-lived intangible asset impairment
     2,005,085.75 8,020,343                  
      goodwill impairment
     49,509,698 8,718,398                  
      other expense:
                        
      loss on equity method investments
     -446,213 -27,035 -38,817 -40,698 -57,480.75 -82,742 -64,014 -83,167    -115,286        
      gain on remeasurement of operating and finance leases
     -10,591.75 5,077   -311 -6,163              
      total other expense
     -608,606.25 -1,192,482 -436,394 -805,549                
      net income before income tax benefit
     -18,972,104 -43,168,791 -17,916,638 -14,802,987       988,565 -6,048,660 -1,976,649 2,868,402 12,077,522 9,812,616    
      net income attributable to stockholders of docgo inc. and subsidiaries
     -134,070,681 -27,768,386 -11,155,246 -9,405,315 -3,262,810 5,497,901 6,529,603 11,227,449 7,570,471 4,764,921 -2,011,267 -3,465,670 8,064,720 3,154,430 12,735,653 10,629,694    
      unrealized gain on investments, net of tax
     -22,832 31,734 76,733                 
      total comprehensive income
     -134,116,762 -28,056,503 -10,151,051 -8,909,777 -4,354,459 6,432,675 6,563,576 11,087,315 8,247,205 4,182,450 -1,605,489 -3,222,012        
      change in fair value of contingent liability
         9,762,845 -44,520 -332,638 6,446 1,277,551 159,974          
      interest income
         -541,464 -505,085 -513,650 -369,008 6,979 346,376 521,872 809,172 465,794 334,221 98,276 -135,606    
      net income before income tax provision
         8,581,064.5 9,034,381 9,567,494 15,722,383 1,024,227.75 9,157,006          
      provision for income taxes
         -3,329,188 -4,488,828              
      net income attributable to noncontrolling interests
         -4,384,116 -952,348 -671,029  422,789 -134,682 3,354,886 -453,120   -979,791     
      gain on remeasurement of warrant liabilities
                 -9,682 -1,831,947 3,027,766     
      gain on equity method investments
             -41,974 -95,503          
      gain on remeasurement of finance leases
             1,208.5 4,834     1,388,273     
      income tax
             -510,460.75 -4,526,767          
      revenue
               125,486,760 113,002,703 108,784,996 104,319,894 109,519,304 117,891,552    
      yoy
               14.58% -4.15%        
      qoq
               11.05% 3.88% 4.28% -4.75% -7.10%     
      gain on initial equity method investments
               -90,573  24,960 93,371 89,810     
      income tax benefit
               355,054 2,129,870   -321,660     
      loss on remeasurement of warrant liabilities
                    -58,749    
      loss on disposal of fixed assets
                -54,839        
      gain from ppp loan forgiveness
                        
      income tax expense
                 -290,938.75 -401,916  -440,179    
      total comprehensive gain
                 6,693,158 3,402,713 12,746,087 10,623,831    
      loss on initial equity method investments
                    -83,341    
      general and administrative expenses
                     244,121.5 348,325 245,345 
      interest earned on investments held in trust account
                     5,651 1,480 4,110 
      change in fair value of warrant liabilities
                     111,417.5 891,332 -2,801,332 
      weighted-average number of class a common shares outstanding, basic and diluted
                      12,656,250 11,500,000 
      basic and diluted net income per class a common share
                     -0.01 0.04  
      weighted-average number of class b common shares outstanding, basic and diluted
                      1,718,750 2,875,000 
      basic and diluted net income per class b common share
                     -0.01 0.04  
      basic and diluted net loss per class b common share
                       -1.06 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 
                          
        assets
                          
        current assets:
                          
        cash and cash equivalents
      35,675,081 51,018,657 73,355,638 104,164,128 79,007,535 89,241,695 89,458,388 66,059,922 41,244,446 59,286,147 52,922,517 109,159,519 120,056,897 157,335,323 169,598,749 198,138,395 188,353,909 175,537,221   
        accounts receivable
      93,965,449 92,893,216 107,015,563 122,756,182 178,755,898 210,899,926 233,712,723 257,503,002 283,127,437 262,083,462 207,324,368 118,498,751 131,599,567 102,995,397 79,999,764 72,253,831 76,167,670 78,383,614   
        prepaid expenses
      5,276,630 4,790,215 4,732,665                  
        other current assets
      3,248,628 3,697,371 5,122,147                  
        total current assets
      138,165,788 152,399,459 190,226,013 236,574,634 262,531,431 304,486,263 328,326,017 328,707,841 335,131,579 338,869,562 267,146,297 234,445,057 258,393,842 271,080,905 251,992,837 275,677,529 268,170,785 256,032,491 287,576 457,056 
        property and equipment
      13,637,905 14,558,427 14,298,994 14,422,298 15,049,767 14,881,411 15,284,753 15,996,793 16,315,633 16,835,484 21,852,663 21,937,494 21,729,460 21,258,175 17,577,830 12,229,997 12,624,427 12,733,889   
        intangibles
      644,134  17,939,190 26,707,383 27,343,578 25,728,813 34,996,541 35,973,775 36,764,034 37,682,928 38,586,498 38,050,268 38,939,054 22,969,246 20,647,790 10,415,401 10,579,310 10,678,049   
        restricted cash and cash equivalents
      11,140,255 1,466,121 4,251,534 4,390,444                 
        restricted investments
      13,119,276 15,845,875 17,574,573 20,114,327                 
        operating lease right-of-use assets
      10,248,516 11,520,781 12,087,775 12,611,145 13,665,630 11,958,698 12,489,767 9,372,463 9,125,733 9,580,535 9,420,525 9,288,582 9,375,132 9,074,277 8,185,547 3,812,085 3,962,805 4,195,682   
        finance lease right-of-use assets
      18,120,270 17,420,424 17,066,242 17,664,270 17,159,190 15,337,299 14,605,119 14,079,838 13,385,131 12,003,919 8,566,308 8,963,759 9,170,429 9,039,663 9,421,196 8,408,399 8,658,897 9,307,113   
        deferred tax assets
      814,032 538,864 30,709,856 17,207,849 12,349,462 8,422,034 17,131,328 13,912,812 11,945,760 11,888,539 8,908,731 11,247,764 10,973,522 9,957,967       
        other assets
      3,336,687 3,353,061 3,093,039 3,148,502 3,580,924 3,730,473 3,432,562 2,298,704 2,407,665 2,565,649 2,928,270 3,538,920 3,350,571 3,625,254 3,095,354 1,682,575 1,622,653 3,810,895   
        total assets
      209,226,863 217,103,012 353,782,879 408,263,751 430,792,998 455,621,132 493,882,539 488,165,687 490,685,117 490,451,957 419,784,142 390,286,045 407,545,176 393,277,628 355,920,210 331,855,388 325,196,304 309,602,652 115,288,058 115,464,516 
        liabilities and stockholders’ equity
                          
        current liabilities:
                          
        accounts payable
      13,866,403 11,110,867 8,052,772 10,122,762 20,518,829 28,356,430 35,141,454 30,804,149 25,628,149 19,827,258 8,951,261 6,690,956 19,028,065 21,582,866 12,153,337 12,915,952 15,120,928 15,833,970 161,067 25,052 
        accrued liabilities
      44,728,154 42,789,440 50,937,332 44,622,283 41,406,981 49,896,796 59,968,606 63,186,648 70,178,256 91,340,609 58,883,665 34,787,144 30,544,082 31,573,031 38,558,074 38,656,519 38,174,025 35,110,877   
        notes payable, current
      49,278 51,740 54,159 12,592 12,931 12,515 26,374 25,501 26,367 28,131 696,053 696,308 649,808 664,913 680,703 566,426 593,831 600,449   
        due to seller
      338,360 336,982 354,037 388,030 1,138,075 28,656 138,275 4,459,079 7,819,147 7,823,009 12,995,455 17,896,030 27,198,044 26,244,133 9,802,238 694,331 1,411,169 1,571,419   
        contingent consideration, current
      8,100,376 3,040,377                   
        operating lease liability, current
      4,288,907 4,650,953 4,597,694 4,693,813 4,447,517 3,844,561 3,776,159 3,011,208 2,835,458 2,773,020 2,561,165 2,479,340 2,353,383 2,325,024 2,059,278 1,421,036 1,404,651 1,461,335   
        finance lease liability, current
      5,845,230 5,509,687 5,275,265 5,359,548 5,099,151 4,694,467 4,435,324 4,115,944 3,866,929 3,534,073 2,733,332 2,717,546 2,773,029 2,732,639 2,858,968 2,655,037 3,262,004 3,271,990   
        total current liabilities
      77,216,708 67,490,046 73,584,133 100,146,642 107,571,098 121,806,577 150,230,713 154,116,875 160,136,043 170,119,082 113,059,417 91,756,618 108,974,683 100,158,490 71,138,479 57,935,182 60,992,489 57,875,921 334,182 163,795 
        notes payable, non-current
      171,714 183,843 195,728  2,155 5,215 21,336 27,329 33,726 41,586 2,044,938 1,580,516 1,272,415 1,236,601 1,456,105 1,048,864 1,171,306 1,302,839   
        contingent consideration, non-current
      2,476,216 4,776,215                   
        operating lease liability, non-current
      6,610,293 7,563,664 8,257,467 8,769,686 9,898,110 8,599,072 9,172,259 6,766,108 6,720,787 7,223,941 7,196,596 7,162,046 7,315,226 7,040,982 6,406,246 2,651,849 2,788,103 2,980,946   
        finance lease liability, non-current
      11,541,541 11,217,907 11,083,664 11,616,691 11,396,832 10,031,138 9,554,694 9,268,771 8,718,460 7,896,392 5,930,776 5,926,286 6,061,828 5,914,164 6,086,521 5,276,312 6,402,846 6,867,420   
        total liabilities
      98,016,472 91,231,675 93,120,992 120,533,019 128,868,195 140,442,002 168,979,002 170,179,083 175,609,016 185,281,001 128,231,727 106,425,466 123,624,152 114,350,237 85,087,351 77,461,692 84,931,995 82,545,628 12,954,182 13,675,127 
        commitments and contingencies
                          
        stockholders’ equity:
                          
        common stock
      9,878 9,864 9,781 9,776 10,018 10,191 10,198 10,168 10,297 10,406   10,293   10,564 10,208    
        additional paid-in-capital
      328,618,933 325,416,366 317,820,318 316,509,060 318,417,191 321,087,583 321,028,986 317,403,960 320,135,875 320,693,866 315,745,338 312,101,281 310,049,864  301,522,213 287,301,467 284,938,732    
        accumulated deficit
      -198,564,926 -183,801,795 -49,731,114 -21,962,728 -10,807,482 -1,402,167  -3,637,258 -10,166,861 -21,394,310 -28,964,781 -33,729,702 -32,367,602  -37,036,937 -40,191,367 -52,927,020  -12,666,412 -5,276,232 
        accumulated other comprehensive income
      2,247,984 2,387,404 2,433,485 2,721,602 1,717,407 1,221,869 2,313,518 1,378,744 1,344,771  808,171 1,390,642         
        total stockholders’ equity attributable to docgo inc. and subsidiaries
      132,311,869 144,011,839 270,532,470 297,277,710 309,337,134 320,917,476 325,213,345 315,155,614 311,324,082  287,599,115 279,772,597 278,677,419  264,219,841 247,092,734 231,983,556    
        noncontrolling interests
      -21,101,478 -18,140,502 -9,870,583 -9,546,978 -7,412,331 -5,738,346 -309,808 2,830,990 3,752,019  3,953,300 4,087,982 5,243,605  6,613,018 7,300,962 8,280,753    
        total stockholders’ equity
      111,210,391 125,871,337 260,661,887 287,730,732 301,924,803 315,179,130 324,903,537 317,986,604 315,076,101  291,552,415 283,860,579 283,921,024  270,832,859 254,393,696 240,264,309   5,000,009 
        total liabilities and stockholders’ equity
      209,226,863 217,103,012 353,782,879 408,263,751 430,792,998 455,621,132 493,882,539 488,165,687 490,685,117  419,784,142 390,286,045 407,545,176  355,920,210 331,855,388 325,196,304   115,464,516 
        goodwill
        41,089,450 49,954,435 49,554,226 47,432,550 47,862,242 47,505,110 47,489,759 47,539,929 47,594,304 47,820,840 47,668,654 38,900,413 34,533,363 8,686,966 8,686,966 8,686,966   
        investments
        5,446,213 5,468,464 5,507,281 5,547,979               
        line of credit
         30,000,000 30,000,000 30,000,000 30,000,000 30,000,000 30,000,000 25,000,000     1,025,881 1,025,881 1,025,881 25,881   
        contingent consideration
        4,312,874 4,947,614 4,947,614 4,973,152 16,744,521 18,514,346 19,781,737 19,792,982 26,238,486 26,489,294 26,428,272 10,555,540 4,000,000      
        prepaid expenses and other current assets
         9,654,324 4,767,998 4,344,642 5,154,906 5,144,917 10,759,696 17,499,953 6,899,412 6,786,787 6,737,378 6,269,841 2,394,324 5,285,303 3,649,206 2,111,656 228,257 222,896 
        restricted cash
          24,051,509 18,095,612 19,120,110 19,763,472 17,649,417 12,931,839 14,333,421 14,601,243 7,461,821 6,773,751 9,753,575 10,323,088 10,370,398 3,568,509   
        equity method investments
            634,100 554,879 470,406 553,573 447,125          
        retained earnings
            1,860,643              
        assets held for sale
                   4,480,344       
        liabilities held for sale
                   4,480,344       
        common stock (0.0001 par value...
                10,387 10,376   10,778      
        equity method investment
                 392,118 482,691 597,977 712,718 619,348 520,063 589,058   
        accumulated other comprehensive gain
                  984,864        
        warrant liabilities
                     10,549,485 13,577,251 13,518,502 8,595,000 9,486,332 
        accumulated other comprehensive loss
                    -276,213 -27,930 -38,364    
        assets:
                          
        cash
                        59,319 234,160 
        investments held in trust account
                        115,000,482 115,007,460 
        liabilities, class a common stock subject to possible redemption, and stockholders’ deficit
                          
        franchise tax payable
                        103,115 68,743 
        other accrued liabilities
                        70,000 70,000 
        deferred underwriting commissions in connection with initial public offering
                        4,025,000 4,025,000 
        class a common stock, 0.0001 par value...
                        115,000,000 96,789,380 
        stockholders’ deficit:
                          
        preferred stock, 0.0001 par value...
                          
        class b common stock, 0.0001 par value...
                         288 
        additional paid-in capital
                         10,275,771 
        total stockholders’ deficit
                        -12,666,124  
        total liabilities, class a common stock subject to possible redemption, and stockholders’ deficit
                        115,288,058  
        liabilities and stockholders’ equity:
                          
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 
                         
          cash flows from operating activities:
                         
          net loss
        -16,699,837                 
          adjustments to reconcile net loss to net cash from operating activities:
                         
          depreciation of property and equipment
        1,266,513 1,180,710 1,249,968 1,211,771 1,220,806 1,323,878 1,374,975 1,476,657 1,431,308 132,063 1,625,070 1,590,037 1,482,610 1,522,102 1,150,806 729,560 711,878 
          amortization of intangible assets
        21,038 1,382,612 1,448,548 1,452,299 1,299,142 776,481 1,605,483 1,583,871 1,694,983 953,400 1,515,378 1,414,944 1,365,636 945,391 990,345 645,715 633,363 
          amortization of finance lease right-of-use assets
        1,359,556 1,384,912 1,272,716 1,316,938 1,241,443 1,222,566 1,197,076 1,141,130 1,056,490 3,529,772 1,195,819 826,080 801,083 844,429 873,713 662,495 855,781 
          loss on disposal of fixed assets
        62,493  10,453               
          deferred income tax expense
        -253,775                 
          accretion of discount related to restricted investments
        -78,004 -94,953 -69,486               
          loss on equity method investments
         446,213 27,035 38,817 40,698 86,121 82,742 64,014 83,167 41,974        
          bad debt expense
        1,732,911 8,341,116 1,214,666 1,244,018 1,247,991 1,378,086 1,086,816 1,413,037 1,357,621 3,912,961 -1,288,131 2,879,277 -1,902,587 1,112,208 884,187 664,557 1,154,235 
          stock-based compensation
        3,224,784 3,135,898 4,649,675 4,826,133 4,830,312 3,878,631 3,155,186 2,611,930 3,988,339 5,807,327        
          loss on remeasurement of operating and finance leases
         -5,077 6,607 40,837 311 6,163 21,192 4,697         
          loss on change in fair value of contingent consideration
        2,760,000 1,003,718                
          changes in operating assets and liabilities:
                         
          accounts receivable
        -2,803,766 11,775,279 14,528,162 54,756,572 31,437,734 21,434,711 21,387,772 20,851,331 -22,401,596 -57,040,937 -88,076,313 9,260,366 -24,668,050 -11,310,443 -1,416,340 3,249,281 1,061,709 
          prepaid expenses and other current assets
        -37,672 2,003,275 -129,747 -4,886,326 -386,734 674,104 -9,989 5,614,779 6,728,337 -10,507,797 -112,625 -49,409 -174,059 -3,898,367 2,890,979 -1,636,097 -1,537,550 
          other assets
        16,374 -616,919 55,463 432,422 538,190 -297,911 -1,133,858 108,961 -62,016 362,621 610,650 -188,349 274,683 675,223 -1,245,888 -59,922 2,188,242 
          accounts payable
        2,700,501 2,680,565 -2,074,591 -10,562,692 -7,684,101 -6,764,153 4,379,590 5,145,678 5,800,891 10,860,517 2,260,305 -12,319,429 -2,581,796 7,620,688 -1,055,891 -2,255,748 -671,744 
          accrued liabilities
        1,938,714 -7,730,838 4,780,386 1,697,323 -9,148,984 -10,444,857 -3,498,801 -7,186,428 -20,810,287 31,649,586 26,120,859 2,669,950 -1,471,551 -8,560,951 -948,755 482,494 3,063,148 
          operating lease liabilities and right-of-use assets
        132,363 -213,609 77,234               
          net cash from operating activities
        -4,657,807 -10,467,300 1,658,736 33,604,751 9,655,467 12,887,115 31,033,393 37,056,306 -10,639,744 -5,918,767 -45,878,329 10,693,169 -23,117,951 -8,737,644 7,420,568 11,922,295 18,264,682 
          capital expenditures
        -430,310 -1,497,058 -876,177 -1,468,364 -893,303 -786,174 -1,202,967 -951,702 -3,223,754 -801,151 -1,583,581 -1,976,075 -1,204,073 -1,052,506 -339,239 -602,416 
          free cash flows
        -5,088,117 -11,964,358 782,559 33,604,751 8,187,103 11,993,812 30,247,219 35,853,339 -11,591,446 -9,142,521 -46,679,480 9,109,588 -25,094,026 -9,941,717 6,368,062 11,583,056 17,662,266 
          cash flows from investing activities:
                         
          purchase of property and equipment
        -430,310 -1,497,058 -876,177               
          purchase of intangibles
        -665,172                 
          acquisition of a business, net of cash acquired
                        
          purchase of restricted investments
        -1,731,066 -3,874,540 -2,517,699               
          proceeds from sale and maturity of restricted investments
        4,463,765 5,675,359                
          proceeds from disposal of property and equipment
        21,903 4,000 20,838 82,988 94,341 95,892 95,822 57,713 25,000 472,878 -3,028 159,818 117,420     
          net cash from investing activities
        1,659,120 -13,072,046 1,099,455 -21,377,184 -5,733,052 -5,571,281 -1,512,591 -2,088,659 -1,699,741 -2,962,151 -1,501,895 -23,727,989 -1,689,495 -654,003 -35,835,883 -821,045 -1,137,040 
          cash flows from financing activities:
                         
          repayments of notes payable
        -14,551 -14,086 -20,903 -3,198 -3,060 -29,980 -5,120 -7,263 -9,624 503,657 -281,876 -118,337 -129,370 -339,440 -297,713 -149,847 -138,151 
          earnout payments on contingent liabilities
         -1,687,134 -265,538 -2,008,524           
          distributions paid to noncontrolling interest
        -1,024,270                
          payments for taxes related to shares withheld for employee taxes
        -22,203 -410,810 -62,547 -139,575 -1,200,977 -794,566 -107,979 -245,386 -20,946 -141,972        
          common stock repurchased
         -5,076,952 -5,751,954 -2,678,073 -1,296,187 -4,904,452 -4,877,559     -3,233,953 140   
          payments on obligations under finance lease
        -1,403,655 -1,419,963 -1,256,945 -1,411,786 -1,296,887 -1,216,409 -1,088,265 -1,060,201 -969,588 -1,977,223 -782,808 -766,492 -744,030 -838,711 -735,292 -788,990 -622,575 
          net cash from financing activities
        -2,464,679 -1,864,710 -33,051,603 -7,382,430 -8,518,416 -7,855,947 -7,350,664 -8,066,648 -881,579  -8,667,411 8,759,937 -11,951,059 -6,865,689 -436,419 -1,374,508 2,496,798 
          effect of exchange rate changes on cash and cash equivalents
        -206,076 281,662 -653,988 650,391 317,738 -701,078 584,966 28,532 -103,059 865,746 -457,189 516,927 168,149 1,014,086 -257,425 10,434 -5,863 
          net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents
        -5,669,442                 
          cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period
        52,484,778               
          cash, cash equivalents, restricted cash and restricted cash equivalents at end of period
        46,815,336 -25,122,394 -30,947,400               
          net income
         -142,340,600 -29,657,362 -13,289,893 -11,079,300 -7,646,926 4,545,553 5,858,574 10,603,379 7,993,260 4,630,239 1,343,619 -3,918,790 7,148,427 2,466,487 11,755,862 9,372,437 
          adjustments to reconcile net income to net cash from (used in) operating activities:
                         
          loss on disposal of assets
               -12,563 -52,835 689,092 9,983 98,630 54,839 63,840    
          deferred income tax
         30,061,721 -13,510,442 -4,878,785 -3,927,428 8,709,292 -3,218,516 -1,968,495 -55,776         
          loss on liquidation of business
                       
          intangible asset impairment
                         
          goodwill impairment
         49,509,698                
          equity investment impairment
                         
          acquisition of businesses, net of cash acquired
                         
          purchase of equity method investments
                        
          purchase of equity securities
                         
          proceeds from revolving credit line
             45,000,000      1,000,000 
          repayments of revolving credit line
            -40,000,000         
          proceeds from notes payable
                        
          due to seller
         -19,851 -106,943   -109,619 -3,005,113 -1 -3,862 -5,172,446 -5,861,748 8,938,361 -11,494,549 -1,527,721 -130,712 -716,838 -160,250 
          acquisition of noncontrolling interest
                        
          proceeds from exercise of stock options
             25,646   31,885 426,003 706,405 416,890 100,017 727,158 779,066 374,344 
          net increase in cash, cash equivalents, restricted cash and restricted cash equivalents
         -25,122,394 -30,947,400               
          adjustments to reconcile net income to net cash from operating activities:
                         
          finite-lived intangible asset impairment
                         
          acquisition of intangibles
          -681,396 -865,462 -712,711 226,130 -660,276 -794,918 -773,039 -62,853 -547,206 -526,158 -1,405,444 -343,124 -940,004 -481,806 -534,624 
          change in fair value of contingent consideration
             -9,762,845 44,520 332,638 -6,446 -1,277,551        
          proceeds from sale of restricted investments
                         
          dividends paid to noncontrolling interest
             -1,044,422           
          gain on disposal of fixed assets
            -15,139             
          acquisition of property and equipment
            -1,468,364 -893,303 -786,174 -1,202,967 -951,702 -3,223,754 -801,151 -1,583,581 -1,976,075 -1,204,073 -1,052,506 -339,239 -602,416 
          acquisition of a business
            -3,646,318             
          net decrease in cash and restricted cash
            -4,278,263    -13,324,123         
          cash and restricted cash at beginning of period
            107,337,307 72,217,986 164,109,074 179,105,730 
          cash and restricted cash at end of period
            103,059,044 -1,241,191 22,755,104 26,929,531 58,893,863 4,962,048 -56,504,824 -3,757,956 127,518,718 -15,243,250 -29,109,159 9,737,176 198,724,307 
          gain on remeasurement of warrant liabilities
                     9,682 1,831,947   
          gain on bargain purchase
                         
          asset held for sale
                         
          acquisition of businesses
                 -21,778,068 1,574,604 890,194    
          equity method investments
             -161,963   -148,422        
          investment in equity securities
                         
          noncontrolling interest contributions
                     2,063,000 
          equity costs
                     -19,570 
          net increase in cash and restricted cash
             -1,241,191 22,755,104   4,962,048 -56,504,824 -3,757,956 -36,590,356 -15,243,250 -29,109,159 9,737,176 19,618,577 
          supplemental disclosure of cash and non-cash transactions:
                         
          cash paid for interest
                         
          cash paid for interest on finance lease liabilities
                         
          cash paid for income taxes
                         
          right-of-use assets obtained in exchange for lease liabilities
                         
          remeasurement of finance lease right-of-use asset due to lease modification
                         
          fixed assets acquired in exchange for notes payable
                         
          supplemental non-cash investing and financing activities:
                         
          acquisition of remaining fmc na through due to seller and issuance of stock
                         
          acquisition of crms through issuance of stock
                         
          crms true-up payment through issuance of stock
                         
          receivable exchanged for trade credits
                         
          pre-acquisition receivables written off through due to seller
                         
          reconciliation of cash and restricted cash
                         
          cash
                         
          restricted cash
                         
          total cash and restricted cash shown in statement of cash flows
                         
          gain on liquidation of business
                    70,284     
          gain from ppp loan forgiveness
                         
          acquisition of leased assets
                         
          acquisition of uk ltd remaining 20% shares
                         
          issuance costs related to merger recapitalization
                         
          proceeds from issuance of class a common stock, net of transaction cost
                         
          net cash provided (used) in financing activities
                         
          due to seller non-cash
                         
          deferred tax asset
                  2,339,033 -274,242 -1,015,555     
          gain on remeasurement of finance leases
                       
          adjustments to reconcile net income to net cash
                         
          from operating activities:
                         
          loss on equity method investment
                   90,573 115,286     
          stock based compensation
                   3,351,122 8,450,016 3,438,515 1,111,195 2,081,924 1,422,937 
          loss on remeasurement of warrant liabilities
                        -58,749 
          gain on equity method investment
                         
          cash held for sale
                         
          investments in equity method investment
                         
          proceeds from revolving line of credit
                         
          repayments of revolving line of credit
                         
          proceeds from fmc loan
                         
          repayments of fmc loan
                         
          acquisition of u.k. ltd remaining 20% shares
                         
          provided by operating activities:
                         
          gain from equity method investment
                      -69,550   
          loss from equity method investment
                        68,995 
          due to seller write off